Aceto Corporation Announces Rising Pharmaceuticals, Inc Subsidiary Launches Generic Version of Soma(R) Compound With Aspirin and Codeine Tablets and Generic Version of Decadron(R) Elixir
4/11/2012 9:57:49 AM
PORT WASHINGTON, N.Y., April 11, 2012 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generic subsidiary, has launched the 200mg/325 mg/16 mg strengths of Carisoprodol, Aspirin and Codeine phosphate Tablets USP, an approved generic version of Meda Pharmaceutical's Soma® Compound with Aspirin and Codeine Tablets, and 0.5mg/5ml strength of Dexamethasone Elixir USP, an approved generic version of Merck & Co., Inc's., Decadron® Elixir, following the U.S. Food and Drug Administration (FDA) approval of both Abbreviated New Drug Applications (ANDA). According to IMS Health data, U.S. brand sales for Carisoprodol, Aspirin and Codeine tablets, which is used to relieve pain and muscle spasms, and Dexamethasone Elixir, which is a steroid used to treat severe allergies, arthritis and asthma, were approximately $5.8 Million collectively for the twelve months ended December, 2011.
comments powered by